Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-02-01 @ 11:44 AM
Study NCT ID:
NCT00525161
Status:
TERMINATED
Last Update Posted:
2015-01-26
First Post:
2007-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Sponsor:
Suleiman Massarweh
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
07-BRE-41-BP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |